StockNews.com Initiates Coverage on ObsEva (NASDAQ:OBSV)

Equities researchers at StockNews.com initiated coverage on shares of ObsEva (NASDAQ:OBSV) in a research report issued to clients and investors on Tuesday. The brokerage set a “hold” rating on the stock.

ObsEva Stock Performance

ObsEva has a 1 year low of $0.08 and a 1 year high of $2.14. The firm has a market cap of $7.94 million, a price-to-earnings ratio of -0.11 and a beta of 0.68. The stock has a fifty day moving average of $0.01.

ObsEva Company Profile

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.